Answers for medical practices
Is AI video HIPAA compliant for medical practices?
Yes, but only if the workflow is built for healthcare marketing rather than generic content generation. By default, no: a medical practice can't treat a consumer AI video tool and a HIPAA-aware production process as the same thing, because the real risk sits in script review, patient-information handling, and the release controls that decide what actually gets published. That's the line. Everything else is sales packaging.
What makes AI video risky for a medical practice?
The risk isn't that video uses artificial intelligence. The risk is that a loose process can let protected health information drift into the script, the prompt, the footage plan, or the final cut without a real review step in the middle.
FMAI's doctors page states the problem plainly: generic AI video is faster but ignores HIPAA. It also says the safer alternative is HIPAA-aware scripting that handles patient privacy, off-label compliance, and FTC advertising rules. That's the useful dividing line for a practice owner. If a vendor talks only about what the model can generate and won't explain who reviews the medical language, who strips out patient-specific details, and what happens before release, the workflow isn't ready for healthcare.
What does a HIPAA-aware AI video workflow look like in practice?
The workflow has to start with controls, not with the model.
On FMAI's doctors page, the live offer is narrow and concrete: educational explainers, procedure walkthroughs, and practice spotlights, built with HIPAA-aware scripting. That specificity matters because those formats create obvious failure points the moment a team gets casual about examples, visuals, or source material pulled too close to a real patient interaction. Sometimes the miss is an unsupported claim in a procedure explainer; sometimes it's a practice spotlight that borrows patient detail too casually, or a walkthrough that reuses specifics that should never leave the chart. That's why the page pairs one identity capture with a compliance pass covering patient privacy, off-label compliance, and FTC advertising rules. If those checks aren't in the process before publication, the tool choice doesn't save you.
Is a generic AI video tool enough for a medical practice?
A generic AI video tool isn't enough on its own.
A generic tool can produce footage fast. That's not the hard part. The hard part is proving that the workflow kept patient information out, kept the claims review in, and kept the release decision with people who understand medical marketing risk. FMAI's own comparison table makes that distinction in black and white: HIPAA-aware scripting is "Yes" for FMAI, "Per-shoot review" for traditional production, and "No" for generic AI video, which is exactly why a flashy sample reel doesn't answer the real compliance question. If you're evaluating vendors, that's the question to press on.
How does FMAI describe its compliance posture?
FMAI doesn't describe healthcare work as a creative free-for-all. It describes a regulated workflow.
The homepage FAQ adds one more concrete point: regulated-industry work sits under Doug Swim, Esq. review, with an audit trail included, so the company is not pitching healthcare video as a model-only service that runs without accountable review. That's a narrow claim, and it's the right one. It doesn't promise that every AI video idea is safe for a medical practice. It tells you the proof point that matters most: somebody specific owns compliance, and there is an audit trail if the work ever has to be examined later.
How fast can a HIPAA-aware workflow move?
It can still move quickly, and that's where weak vendors usually overtalk.
FMAI's doctors page says first cut in 3 to 5 days while the workflow still handles patient privacy, off-label compliance, and FTC advertising rules. Good. That's fast enough to matter for a practice that needs a steady stream of patient education or specialist-positioning video because the workflow is standardized around the same review checkpoints each time, instead of being rebuilt from scratch for every shoot.
Where FMAI fits
FMAI's position isn't that AI video is magically HIPAA compliant. Its position is tighter than that, and more believable: medical-practice video can work when the workflow is HIPAA-aware, privacy-conscious, and reviewed before release.
If a studio can't tell you who owns compliance, what review happens before publish, and how a first cut still lands in 3 to 5 days without skipping those controls, stop there. You're not looking at a healthcare-ready workflow. You're looking at a demo.
Related questions
If you're pressure-testing a vendor, ask the next layer of questions directly: What should a medical practice look for in a HIPAA-aware AI video workflow?, Can AI video be used for patient education without creating privacy risk?, and How fast can a medical practice get an AI video first cut?.